Calcium-dependent interaction of calcineurin with Bcl-2 in neuronal tissue

Neuroscience

Volumn 117, Issue 3, 2003, Pages 541-555

  Erin, N ^a   Bronson, S K ^a   Billingsley, M L ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Calmodulin; IP3 R; Ischemia; Phosphatase

Indexed keywords

CALCINEURIN; CALCIUM; CALMODULIN; INOSITOL TRISPHOSPHATE; N METHYL DEXTRO ASPARTIC ACID; PROTEIN BCL 2; RECEPTOR; THAPSIGARGIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL FREE SYSTEM; CELL NUCLEUS; CELLULAR DISTRIBUTION; CLINICAL OBSERVATION; CONTROLLED STUDY; CYTOSOL; DEPHOSPHORYLATION; HYPOXIA; IMMUNOPRECIPITATION; IN VITRO STUDY; MALE; MICROSOME; MITOCHONDRION; MOUSE; NERVOUS TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RAT; WILD TYPE;

EID: 0344642938     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00933-8     Document Type: Article

References (54)

1. Ali H., Christensen S.B., Foreman J.C., Pearce L., Piotrowski W., Thastrup O. The ability of thapsigargin and thapsigargicin to activate cells involved in the inflammatory response. Br J Pharmacol. 85:1985;705-712.
2. Ankarcrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., Nikotera P. A succession of necrosis or apoptosis depending on mitochondrial function. Neuron. 15:1995;961-973.
3. Asai A., Qiu J., Narita Y., Chi S., Saito N., Shinoura N., Hamada H., Kuchino Y., Kirino T. High level of calcineurin activity predisposes neuronal cells to apoptosis. J Biol Chem. 274:1999;34450-34458.
4. Bederson J.B., Pitts L.H., Germano S.M., Nishimura M.C., Davis R.L., Bartkowski H.M. Evaluation of 2,3,5-triphenylterazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 17:1986;1304-1308.
5. Billingsley M.L., Kincaid R.L. Regulated phosphorylation and dephosphorylation of tau protein effects of microtubule interaction, intracellular trafficking and neurodegeneration . Biochem J. 323:1997;577-591.
6. Biswas R.S., Cha H.J., Hardwick J.M., Srivastava R.K. Inhibition of drug-induced Fas ligand transcription and apoptosis by Bcl-XL. Mol Cell Biochem. 225:2001;7-20.
7. Breitschopf K., Haendeler J., Malchow P., Zeiher A.M., Dimmeler S. Posttranslational modification of Bcl-2 facilitates its protaseome-dependent degradation molecular characterization of the involved signaling pathway . Mol Cell Biol. 20:2000;1886-1896.
8. Bronson S.K., Plaehn E.G., Kluckman K.D., Hagaman J.R., Maeda N., Smithies O. Single-copy transgenic mice with chosen-site integration. Proc Natl Acad Sci USA. 93:1996;9067-9072.
9. Budd S.L., Lipton S.A. Signaling events in NMDA receptor-induced apoptosis in cerebrocortical cultures. Ann NY Acad Sci. 893:1999;261-264.
10. Burkart K.K., Beard D.C., Lehman R.A.W., Billingsley M.L. Alterations in tau phosphorylation in rat and human neocortical brain slices following hypoxia and glucose deprivation. Exp Neurol. 154:1998;464-472.
11. 2+ flux. Cell. 83:1995;463-472.
12. Chadebech P., Brichese L., Baldin V., Vidal S., Valette A. Phosphorylation and proteasome-dependent degradation of Bcl-2 in mitotic-arrested cells after microtubule damage. Biochem Biophys Res Commun. 262:1999;823-827.
13. Christensen S.B., Larsen I.K., Rasmussen U. Thapsigargin and thapsigargicin, two histamine liberating sesquiterpene lactones from Thapsia garganica. X-ray analysis of the 7,11-epoxide of thapsigargin. J Org Chem. 47:1982;649-652.
14. Cohen P. The structures and regulation of protein phosphatases. Annu Rev Biochem. 58:1989;453-508.
15. 2+ dysregulation with brain aging. J Neurosci. 21:2001;4066-4073.
16. Furuichi T., Simon-Chazottes D., Fujino I., Yamada N., Hasegawa T., Yoshikawa S., Gueneet J.L., Mikoshiba K. Widespread expression of inositol 1,4,5-trisphophate receptor type 1 gene (insp3r1) in the mouse central nervous system. Recept Channels. 1:1993;11-24.
17. Garcia I., Martinou I., Tsujimoto Y., Martinou J.C. Prevention of programmed cell death of sympathetic neurons by the Bcl-2 protooncogene. Science. 258:1992;302-304.
18. Griffith J.P., Kim J.L., Kim E.E., Sintchak M.D., Thomson J.A., Fitzgibbon M.J., Fleming M.A., Caron P.R., Hsiao K., Navia M.A. X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP-12-FK-506 complex. Cell. 82:1995;507-522.
19. Guo Q., Sopher B.L., Furukawa K., Pham D.G., Robinson N., Martin G.M., Mattson M.P. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide involvement of calcium and oxyradicals . J Neurosci. 17:1997;4212-4422.
20. Hashimoto Y., Perrino B.A., Soderling T.R. Identification of an autoinhibitory domain in calcineurin. J Biol Chem. 265:1990;1924-1927.
21. He H., Lam M., McCormick T.S., Distelhorst C.W. Maintenance of calcium homeostasis in the endoplasmic reticulum by Bcl-2. J Cell Biol. 138:1997;1219-1228.
22. Ikonomidou C., Bosch F., Miksa M., Bittigau P., Vockler J., Dikranian K., Tenkova T.I., Stefovska V., Turski L., Olney J.W. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science. 283:1999;70-74.
23. Kass I.S., Lipton P. Calcium and long term transmission damage following anoxia in dantate gyrus and CA1 region of hippocampal slice. J Physiol (Lond). 378:1986;313-334.
24. Klee C.B., Draetta G.F., Hubbard M.J. Calcineurin. Adv Enzymol. 61:1988;149-200.
25. Krajewski S., Tanaka S., Takayama M.J., Schibler W., Fenton W., Reed J.C. Investigation of the subcellular distribution of the Bcl-2 oncoprotein residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membrane . Cancer Res. 53:1993;4701-4714.
26. Kuo T.H., Kim H.R., Zhu L., Yu Y., Lin H.M., Tsang W. Modulation of endoplasmic reticulum calcium pump by bcl-2. Oncogene. 17:1998;. 1903-1010.
27. Lee J.M., Zipfe G.J., Choi D.W. The changing landscape of ischemic brain injury mechanisms. Nature. 399:1999;A7-A14.
28. Liu J., Farmer J.D. Jr, Lane W.S., Friedman J., Weissman I., Schreiber S.L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Trends Pharmacol Sci. 14:1991;182-188.
29. Mah S.P., Zhong L.T., Liu Y., Roghani A., Edwards R.H., Bredesen D.E. The protooncogene Bcl-2 inhibits apoptosis in PC12 cells. J Neurochem. 60:1993;1183-1186.
30. Martinou J.C., Dubois-Dauphin M., Stable J.K., Rodriguez I., Frankowski H., Missotten M., Albertini P., Talabot D., Catsicas S., Pietra C., Huarte J. Overexpression of Bcl-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron. 13:1994;1017-1030.
31. Motamedi H., Shafiee A., Cai S.J., Streicher S.L., Arison B.H., Miller R.R. Characterization of methytransferase and hydrolase genes involved in the biosynthesis of the immunosuppressants FK506 and FK520. J Bacteriol. 178:1996;5243-5248.
32. Nitatori T., Sato N., Waguri S., Karasawa Y., Araki H., Shibanai K., Kominami E., Uchiyama Y. Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia in apoptosis. J Neurosci. 15:1995;1001-1011.
33. Nunez G., London L., Hockenbery D., Alexander M., McKearn J.P., Korsmeyer S.J. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol. 144:1990;3602-3610.
34. Paschen W., Doutheil J., Corneil G., Treiman M. Depletion of neuronal endoplasmic reticulum calcium stores by thapsigargin effect on protein synthesis . J Neurochem. 67:1996;1735-1743.
35. Paschen W., Doutheil J. Disturbances of the functioning of endoplasmic reticulum; a key mechanism underlying neuronal cell injury. J Cereb Blood Flow Metab. 19:1999;1-18.
36. Pringle A.K., Iannotti F., Wilde G.J.C., Chad J.E., Seeley P.J., Sundstorm L.E. Neuroprotection by both NMDA and non-NMDA receptor antagonists in vitro ischemia. Brain Res. 1555:1997;36-46.
37. Reed J.C. Double identity for proteins of the Bcl-2 family. Nature. 387:1997;773-776.
38. Ruvolo P., Deng X., Carr B.K., May W.S. A functional role for mitochondrial protein kinase C in Bcl-2 phosphorylation and suppression of apoptosis. J Biol Chem. 273:1998;25436-25442.
39. Schurr A., Rigor B.M. Cerebral ischemia revisited new insights as revealed using in vitro brain slice preparations . Experientia. 45:1989;648-695.
40. Shibasaki F., Kondo E., Akagi T., McKeon F. Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature. 386:1997;728-731.
41. 2+)-activated cell death in mammalian cells. J Cell Biol. 131:1995;735-743.
42. Shitashige M., Tou M., Yano T., Shibata M., Matsuo Y., Shibasaki F. Dissociation of Bax from a Bcl-2/Bax heterodimer triggered by phosphorylation of serine 70 of Bcl-2. J Biochem. 130:2001;741-748.
43. Simon R.P., Swan J.H., Griffiths T., Meldrum B.S. Blockage of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science. 226:1984;850-852.
44. Simonian N.A., Getz R.L., Leveque J.C., Konradi C., Coyle J.T. Kainate induces apoptosis in neurons. Neuroscience. 74:1996;675-683.
45. Springer J.E., Azbill R.D., Nottingham S.A., Kennedy S.E. Calcineurin-mediated BAD dephosphorylation activates the caspase-3 apoptotic cascade in traumatic spinal cord injury. J Neurosci. 20:2000;7246-7251.
46. Srivastava R.K., Mi Q.S., Hardwick J.M., Longo D.L. Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis. Proc Natl Acad Sci USA. 96:1999;3775-3780.
47. 2(+)-ATPase. PNAS. 87:1990;2466-2470.
48. Tong G., Shepherd D., Jahr C.E. Synaptic desensitization of NMDA receptors by calcineurin. Science. 267:1995;510-512.
49. 2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science. 284:1999;339-343.
50. Wei H., Perry D.C. Dantrolene is cytoprotective in two models of neuronal cell death. J Neurochem. 67:1996;2390-2390.
51. Ueno H., Kondo E., Yamamoto-Honda R., Tobe K., Nakamoto T., Sasaki K., Mitani K., Furusaka A., Tanaka T., Tsujimoto Y., Kadowaki T., Hirai H. Association of insulin receptor substrate proteins with Bcl-2 and their effects on its phosphorylation and anti-apoptotic function. Mol Biol Cell. 11:2000;735-746.
52. Yakel J.L. Calcineurin regulation of synaptic function from ion channels to transmitter release and gene transcription . Trends Pharmacol Sci. 18:1997;125-134.
53. Yamamoto K., Ichijo H., Korsmeyer S.J. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol Cell Biol. 19:1999;8469-8478.
54. Yokote H., Terada T., Matsumoto H., Kakishita K., Kinoshita Y., Nakao N., Nakai K., Itakura T. Dephosphorylation-induced decrease of anti-apoptotic function of Bcl-2 in neuronally differentiated P19 cells following ischemic insults. Brain Res. 857:2000;78-86.